Guidelines & standards

The guidelines are under the auspices of the bodies of the European Association of Nuclear Medicine (EANM).

• Cardiology
  » EANM/ESC procedural guidelines for myocardial perfusion imaging in nuclear cardiology
  » EANM/ESC guidelines for radionuclide imaging of cardiac function
  
• Dosimetry
  » EANM Dosimetry Committee series on standard operational procedures for pre-therapeutic dosimetry I: blood and bone marrow dosimetry in differentiated thyroid cancer therapy
  
• Paediatric Nuclear Medicine
  » Bone scintigraphy in children
  » 99mTc-DMSA scintigraphy in children
  » Glomerular Filtration Rate Determination in Children
  » Indirect Radionuclide Cystography
  » Standard and Diuretic Renogram in Children
  
• Drug Development
  » Guideline to regulations for radiopharmaceuticals in early phase clinical trials in the EU
  
• Neuroimaging
  » Brain Tumour Imaging using Labelled Amino Acid Analogues
  » Brain Imaging using [18F]FDG
  » Brain Neurotransmission SPET using 123I-labelled Dopamine D2 Receptor Ligands
  » Brain Neurotransmission SPET using 123I-labelled Dopamine Transporter Ligands
  » Brain Perfusion SPET using 99mTc-labelled Radiopharmaceuticals
  
• Oncology
  » Bone Scintigraphy
  » Breast Scintigraphy
  » FDG-PET
  » 67Ga Scintigraphy - Procedures Guidelines For Tumour Imaging
  » 131I/123I-Metaiodobenzylguanidine (MIBG) Scintigraphy
  
• Radionuclide Therapy
  » Guidelines for 131I - ethiodised oil [Lipiodol] Therapy
  
• Technologist Guidelines
  » Advanced Performance and Responsibility Guidelines
  » Entry Level Competencies
  » Working with Protocols
  » Patient information leaflets
  
• Radiopharmacy
  » Guidelines on Current Good Radiopharmacy Practices (cGRPP) for kit-based Radiopharmaceuticals in Nuclear Medicine
  » Guidelines on Current Good Radiopharmacy Practices (cGRPP) for Positron Emission Tomography (PET) and other Locally Prepared Radiopharmaceuticals